Activity of sunitinib in extraskeletal myxoid chondrosarcoma

European Journal of Cancer

Volumn 50, Issue 9, 2014, Pages 1657-1664

  Stacchiotti, S ^a   Pantaleo, M A ^b   Astolfi, A ^b   Dagrada, G P ^a   Negri, T ^a   Dei Tos, A P ^c   Indio, V ^b   Morosi, C ^a   Gronchi, A ^a   Colombo, C ^a   Conca, E ^a   Toffolatti, L ^c   Tazzari, M ^a   Crippa, F ^a   Maestro, R ^d   Pilotti, S ^a   Casali, P G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c General Hospital of Treviso   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Antiangiogenic; Chemotherapy; Chondrosarcoma; Extraskeletal myxoid chondrosarcoma; Sarcoma; Sunitinib

Indexed keywords

CD135 ANTIGEN; NUCLEAR RECEPTOR NR4A3; PROTEIN RET; PROTEIN TYROSINE KINASE; SUNITINIB; TRANSCRIPTOME; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CHEMICAL ANALYSIS; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHONDROSARCOMA; CLINICAL ARTICLE; DIARRHEA; DRUG ACTIVITY; DRUG DOSE INCREASE; EXTRASKELETAL MYXOID CHONDROSARCOMA; FATIGUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE PHENOTYPE CORRELATION; HAND FOOT SYNDROME; HUMAN; HYPERTENSION; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOLECULAR DIAGNOSIS; MUCOSA INFLAMMATION; NEUTROPENIA; ONCOGENE C KIT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RARE DISEASE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SURGICAL INFECTION; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR BLEEDING;

ANTIANGIOGENIC; CHEMOTHERAPY; CHONDROSARCOMA; EXTRASKELETAL MYXOID CHONDROSARCOMA; SARCOMA; SUNITINIB;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CALMODULIN-BINDING PROTEINS; CHONDROSARCOMA; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENE REARRANGEMENT; GENOTYPE; HUMANS; INDOLES; MALE; MIDDLE AGED; NEOPLASMS, CONNECTIVE AND SOFT TISSUE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS C-RET; PYRROLES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; RNA-BINDING PROTEINS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84901190717     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.03.013     Document Type: Article

References (16)

1. C.D.M. Fletcher et al. World Health Organization (WHO) classification of tumours of soft tissue and bone. Pathology and genetics 2013 IARC Press Lyon
2. S.H. Hinrichs, M.A. Jaramillo, and P.H. Gumerlock et al. Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22 Cancer Genet Cytogenet 14 1985 219 226
3. C.R. Antonescu, P. Argani, and R.A. Erlandson et al. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study Cancer 83 1998 1504 1521
4. K. Ogura, T. Fujiwara, and Y. Beppu et al. Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up Arch Orthop Trauma Surg 132 2012 1379 1386
5. A.D. Drilon, S. Popat, and G. Bhuchar et al. Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy Cancer 113 2008 3364 3371
6. S.R. Patel, M.A. Burgess, and N.E. Papadopoulos et al. Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy Am J Clin Oncol 18 1995 161 163
7. Stacchiotti S, Dagrada G, Sanfilippo R, et al. Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study. Clin Sarcoma Res, in press.
8. S. Stacchiotti, G. Dagrada, and C. Morosi et al. Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib Clinical Sarcoma Research 2 2012 22
9. F. Perrone, S. Tabano, and F. Colombo et al. P15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors Clin Cancer Res 9 2003 4132 4138
10. S. Stacchiotti, T. Negri, and N. Zaffaroni et al. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect Ann Oncol 22 2010 1682 1690
11. H.Dr. Kovar Jekyll and Mr. Hyde: the two faces of the FUS/EWS/TAF15 protein family Sarcoma. 2011 2011 837474 10.1155/2011/837474
12. Y. Labelle, J. Bussières, and F. Courjal et al. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator Oncogene 18 1999 3303 3308
13. S. Kim, H.J. Lee, and H.J. Jun et al. The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator Int J Cancer. 122 2008 2446 2453
14. J. Blechingberg, Y. Luo, and L. Bolund et al. Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions PLoS One 2012 10.1371/journal.pone.0046251
15. J.L. Hoell, E. Larsson, and S. Runge et al. RNA targets of wild-type and mutant FET family proteins Nat Struct Mol Biol 18 2011 1428 1431
16. F. Morohoshi, K. Arai, and E.I. Takahashi et al. Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins Genomics 38 1996 51 57